1. Home
  2. ALT vs LTBR Comparison

ALT vs LTBR Comparison

Compare ALT & LTBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • LTBR
  • Stock Information
  • Founded
  • ALT 1997
  • LTBR 1992
  • Country
  • ALT United States
  • LTBR United States
  • Employees
  • ALT N/A
  • LTBR N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • LTBR Professional Services
  • Sector
  • ALT Health Care
  • LTBR Consumer Discretionary
  • Exchange
  • ALT Nasdaq
  • LTBR Nasdaq
  • Market Cap
  • ALT 397.4M
  • LTBR 326.6M
  • IPO Year
  • ALT N/A
  • LTBR N/A
  • Fundamental
  • Price
  • ALT $4.19
  • LTBR $11.97
  • Analyst Decision
  • ALT Strong Buy
  • LTBR
  • Analyst Count
  • ALT 6
  • LTBR 0
  • Target Price
  • ALT $18.20
  • LTBR N/A
  • AVG Volume (30 Days)
  • ALT 11.7M
  • LTBR 1.6M
  • Earning Date
  • ALT 08-07-2025
  • LTBR 07-30-2025
  • Dividend Yield
  • ALT N/A
  • LTBR N/A
  • EPS Growth
  • ALT N/A
  • LTBR N/A
  • EPS
  • ALT N/A
  • LTBR N/A
  • Revenue
  • ALT $20,000.00
  • LTBR N/A
  • Revenue This Year
  • ALT N/A
  • LTBR N/A
  • Revenue Next Year
  • ALT $1,557,547.90
  • LTBR N/A
  • P/E Ratio
  • ALT N/A
  • LTBR N/A
  • Revenue Growth
  • ALT N/A
  • LTBR N/A
  • 52 Week Low
  • ALT $2.90
  • LTBR $2.24
  • 52 Week High
  • ALT $11.16
  • LTBR $17.70
  • Technical
  • Relative Strength Index (RSI)
  • ALT 39.67
  • LTBR 42.87
  • Support Level
  • ALT $4.33
  • LTBR $11.64
  • Resistance Level
  • ALT $4.79
  • LTBR $13.29
  • Average True Range (ATR)
  • ALT 0.52
  • LTBR 0.91
  • MACD
  • ALT -0.16
  • LTBR -0.23
  • Stochastic Oscillator
  • ALT 26.92
  • LTBR 10.75

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About LTBR Lightbridge Corporation

Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through one business segment, which is the development and commercialization of its nuclear fuel. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.

Share on Social Networks: